Core Insights - Mayville Engineering (MEC) reported quarterly earnings of $0.1 per share, exceeding the Zacks Consensus Estimate of $0.05 per share, but down from $0.14 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company achieved revenues of $144.31 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.65% and up from $135.39 million year-over-year [2] - The stock has increased approximately 12.3% since the beginning of the year, compared to a 16.5% gain for the S&P 500 [3] Earnings Outlook - The future performance of Mayville Engineering's stock will largely depend on management's commentary during the earnings call and the earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $130.87 million, while for the current fiscal year, it is $0.15 on revenues of $540.76 million [7] Industry Context - The Engineering - R and D Services industry, to which Mayville Engineering belongs, is currently ranked in the bottom 38% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which may impact investor sentiment [5]

分组1 - PTC Therapeutics reported quarterly earnings of $0.2 per share, significantly beating the Zacks Consensus Estimate of a loss of $1.19 per share, and showing improvement from a loss of $1.39 per share a year ago, resulting in an earnings surprise of +116.81% [1] - The company achieved revenues of $211.01 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 20.17%, and up from $196.79 million in the same quarter last year [2] - PTC Therapeutics has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has increased approximately 50.5% since the beginning of the year, outperforming the S&P 500, which gained 16.5% [3] - The future performance of PTC Therapeutics' stock will depend on management's commentary during the earnings call and the company's earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is -$0.98 on revenues of $189.42 million, and for the current fiscal year, it is $7.72 on revenues of $1.72 billion [7] 分组3 - The Medical - Biomedical and Genetics industry, to which PTC Therapeutics belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into stock performance [5]

Core Insights - Nexa Resources S.A. reported a quarterly loss of $0.03 per share, missing the Zacks Consensus Estimate of $0.11, and compared to earnings of $0.02 per share a year ago, representing an earnings surprise of -127.27% [1] - The company posted revenues of $763.5 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.17%, but showing an increase from year-ago revenues of $709.48 million [2] - Nexa Resources shares have declined approximately 36.7% since the beginning of the year, contrasting with the S&P 500's gain of 17.2% [3] Earnings Outlook - The future performance of Nexa Resources' stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.18 on revenues of $787.08 million, and for the current fiscal year, it is $0.57 on revenues of $2.89 billion [7] Industry Context - The Mining - Miscellaneous industry, to which Nexa Resources belongs, is currently ranked in the top 25% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5][6]

分组1 - Employers Holdings (EIG) reported a quarterly loss of $1.1 per share, significantly missing the Zacks Consensus Estimate of $0.61, and down from earnings of $0.81 per share a year ago, representing an earnings surprise of -280.33% [1] - The company posted revenues of $239.3 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 11.36%, and up from $224 million in the same quarter last year [2] - Employers Holdings shares have declined approximately 21.4% year-to-date, contrasting with the S&P 500's gain of 17.2% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.61 on revenues of $215.71 million, and for the current fiscal year, it is $2.55 on revenues of $879.5 million [7] - The Zacks Industry Rank for Insurance - Accident and Health is currently in the bottom 33% of over 250 Zacks industries, indicating potential challenges for stocks in this sector [8] 分组3 - The estimate revisions trend for Employers Holdings was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6]

分组1 - LPL Financial Holdings Inc. reported quarterly earnings of $5.2 per share, exceeding the Zacks Consensus Estimate of $4.47 per share, and showing an increase from $4.16 per share a year ago, resulting in an earnings surprise of +16.33% [1] - The company achieved revenues of $4.49 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.65%, and up from $3.11 billion in the same quarter last year [2] - LPL Financial has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] 分组2 - The stock has underperformed the market with a gain of about 5.2% since the beginning of the year, compared to the S&P 500's gain of 17.2% [3] - The current consensus EPS estimate for the upcoming quarter is $4.71 on revenues of $4.75 billion, and for the current fiscal year, it is $18.80 on revenues of $16.56 billion [7] - The Financial - Investment Bank industry, to which LPL Financial belongs, is currently ranked in the top 11% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Core Insights - Emcor Group reported quarterly earnings of $6.57 per share, missing the Zacks Consensus Estimate of $6.65 per share, but showing an increase from $5.8 per share a year ago, resulting in an earnings surprise of -1.20% [1] - The company posted revenues of $4.3 billion for the quarter ended September 2025, which was below the Zacks Consensus Estimate by 0.37%, and an increase from $3.7 billion year-over-year [2] - Emcor Group shares have increased approximately 71.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 17.2% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $6.64 on revenues of $4.33 billion, and for the current fiscal year, it is $25.19 on revenues of $16.81 billion [7] Industry Context - The Building Products - Heavy Construction industry, to which Emcor Group belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Emcor Group's stock performance [5][6]

分组1 - CNX Resources Corporation reported quarterly earnings of $0.49 per share, exceeding the Zacks Consensus Estimate of $0.37 per share, and showing an increase from $0.41 per share a year ago, resulting in an earnings surprise of +32.43% [1] - The company achieved revenues of $423 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 15.60%, compared to $354 million in the same quarter last year [2] - Over the last four quarters, CNX Resources has consistently surpassed consensus EPS estimates, achieving this four times [2] 分组2 - The stock has underperformed, losing about 13.4% since the beginning of the year, while the S&P 500 has gained 17.2% [3] - The current consensus EPS estimate for the upcoming quarter is $0.37 on revenues of $374.1 million, and for the current fiscal year, it is $2.17 on revenues of $1.78 billion [7] - The Zacks Industry Rank for Oil and Gas - Exploration and Production - United States is in the bottom 17% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Core Insights - Agios Pharmaceuticals reported a quarterly loss of $1.78 per share, better than the Zacks Consensus Estimate of a loss of $1.93, representing an earnings surprise of +7.77% [1] - The company generated revenues of $12.88 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 27.69% and up from $8.96 million a year ago [2] - Agios Pharmaceuticals shares have increased by approximately 27.7% year-to-date, outperforming the S&P 500's gain of 17.2% [3] Financial Performance - Over the last four quarters, Agios Pharmaceuticals has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] - The current consensus EPS estimate for the upcoming quarter is -$2.04 on revenues of $10.91 million, and for the current fiscal year, it is -$7.47 on revenues of $42.13 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Agios Pharmaceuticals belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment [5]

Core Viewpoint - Redwood Trust (RWT) reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.16 per share, and showing an increase from $0.18 per share a year ago, representing an earnings surprise of +25.00% [1][2] Financial Performance - The company posted revenues of $15 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 50.02%, and down from $25.5 million year-over-year [2] - Over the last four quarters, Redwood Trust has surpassed consensus EPS estimates only once [2] Stock Performance - Redwood Trust shares have declined approximately 14.2% since the beginning of the year, while the S&P 500 has gained 17.2% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.17 on revenues of $32.47 million, and for the current fiscal year, it is $0.70 on revenues of $104.3 million [7] - The trend of estimate revisions for Redwood Trust was favorable prior to the earnings release, which may influence future stock movements [5][6] Industry Context - The REIT and Equity Trust industry, to which Redwood Trust belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Financial Performance - Blue Foundry Bancorp reported a quarterly loss of $0.1 per share, which aligns with the Zacks Consensus Estimate, compared to a loss of $0.19 per share a year ago [1] - The company posted revenues of $12.61 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 2.08%, and up from $9.47 million in the same quarter last year [2] - Over the last four quarters, Blue Foundry Bancorp has surpassed consensus EPS estimates three times [1][2] Market Performance - Blue Foundry Bancorp shares have declined approximately 12.1% since the beginning of the year, while the S&P 500 has gained 17.2% [3] - The company's current Zacks Rank is 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.07 on revenues of $12.92 million, and -$0.39 on revenues of $48.64 million for the current fiscal year [7] - The trend of estimate revisions for Blue Foundry Bancorp was mixed ahead of the earnings release, which could change following the recent report [6] Industry Context - The Banks - Northeast industry, to which Blue Foundry Bancorp belongs, is currently ranked in the top 14% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]